Clinical trial
Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation…
NCT00072527 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00072527 |
|---|---|
| Title | Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer |
| Official title | Induction Cisplatin/Irinotecan Followed By Combination Carboplatin, Etoposide And Chest Radiotherapy In Limited Stage Small Cell Lung Cancer: A Phase II Study |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, cisplatin, etoposide, irinotecan hydrochloride, radiation therapy |
| Enrollment | 78 |
| Start date | Nov 1, 2003 |
| Primary completion | Jun 1, 2007 |
| Completion | Jan 1, 2013 |
| First posted | Nov 5, 2003 |
| Last update posted | Jul 6, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: